Description

N[[1-(1-Cyclohexen-1-Ylmethyl)Pyrrolidin-2-Yl]Methyl]-3,4-Dihydro-8-[(Methylamino)Sulphonyl]-2H-Benzo-1,5-Dioxepin-6-Carboxamide CAS NO 93980-97-3 is a complex, high-purity organic compound characterized by its unique heterocyclic structure. This molecule is of significant interest for advanced research and development, particularly in the pharmaceutical and life sciences sectors. It serves as a critical intermediate or active pharmaceutical ingredient (API) for researchers and manufacturers developing novel therapeutic agents.

Application

This specialized chemical is designed for high-value applications in research and regulated manufacturing environments.

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of novel drug candidates, particularly in central nervous system (CNS) or metabolic disorder research.
• Active Pharmaceutical Ingredient (API) Development: Used in preclinical and clinical-stage research for the development of new therapeutic compounds.
• Biochemical Research: Employed as a tool compound in pharmacological studies to investigate specific biological pathways and receptor interactions.
• Process Chemistry & Scale-Up: Utilized in process optimization and scale-up activities from laboratory to pilot plant scale.
• Reference Standard: Acts as a high-purity analytical standard for quality control and method development in analytical laboratories.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects.

Basic Information

Product Name	N[[1-(1-Cyclohexen-1-Ylmethyl)Pyrrolidin-2-Yl]Methyl]-3,4-Dihydro-8-[(Methylamino)Sulphonyl]-2H-Benzo-1,5-Dioxepin-6-Carboxamide
CAS No.	93980-97-3
Molecular Formula	C25H35N3O5S
Molecular Weight	489.63 g/mol
Synonyms	Benzo-1,5-dioxepin-6-carboxamide, N-[[1-(1-cyclohexen-1-ylmethyl)-2-pyrrolidinyl]methyl]-3,4-dihydro-8-[(methylamino)sulfonyl]-; L-689,660; L689660; (S)-N-[[1-[(1-Cyclohexen-1-yl)methyl]-2-pyrrolidinyl]methyl]-3,4-dihydro-8-[(methylamino)sulfonyl]-2H-1,5-benzodioxepin-6-carboxamide; NK-1 Receptor Antagonist L-689,660; GR-205,171 (often confused, verify structure); Potential tachykinin antagonist intermediate.
EINECS	Contact for details

Quality Control

Our production of N[[1-(1-Cyclohexen-1-Ylmethyl)Pyrrolidin-2-Yl]Methyl]-3,4-Dihydro-8-[(Methylamino)Sulphonyl]-2H-Benzo-1,5-Dioxepin-6-Carboxamide adheres to stringent quality management systems. Each batch is manufactured under controlled conditions and undergoes comprehensive analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all specifications and test results are provided and can be tailored to meet specific client or regulatory requirements (e.g., ICH guidelines, internal specifications).

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as specified on the label or COA. The compound may be hygroscopic (moisture-sensitive); therefore, containers should be kept tightly sealed in a dry environment. For long-term storage, consider under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥98.0% (Area %)
Water Content (KF)	≤0.5%
Residue on Ignition	≤0.1%
Heavy Metals	≤10 ppm
Specific Rotation	Contact for details

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.